Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma
about
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunityIdentification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.DNA vaccination: using the patient's immune system to overcome cancerTyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma.Using monoclonal antibodies to stimulate antitumor cellular immunity.Antibody-based therapy in colorectal cancer.Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
P2860
Q28749317-342C0CB4-DF40-4846-A54B-7A1B480C133EQ30436422-159C1836-E1C9-40F3-92BF-5FC21DF97A58Q35527105-CF3460A3-FB5A-46D2-A7CA-6BF40A575663Q35877000-05D901BA-4062-4A80-BC9E-D145C64354D0Q36455017-E0F77095-8DB6-45A4-B955-499ECF23EB71Q36759294-5508E91E-C4C1-456E-A9B9-A61ABDF3B560Q37825422-255AFA06-AF7D-45EA-AEA2-73E318DD335CQ37842937-B2B9FB07-ED90-434B-9104-397E75069286Q37909430-3D905B96-3E8D-4BBA-B199-F275B87AC0EAQ38103583-FDA25560-13C8-4ADA-8981-9605F12040E8Q50220559-10176238-3A33-4D5F-90C2-B2670CCA1541
P2860
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improved tumor immunity using ...... NA vaccines in murine melanoma
@en
Improved tumor immunity using ...... A vaccines in murine melanoma.
@nl
type
label
Improved tumor immunity using ...... NA vaccines in murine melanoma
@en
Improved tumor immunity using ...... A vaccines in murine melanoma.
@nl
prefLabel
Improved tumor immunity using ...... NA vaccines in murine melanoma
@en
Improved tumor immunity using ...... A vaccines in murine melanoma.
@nl
P2093
P2860
P1433
P1476
Improved tumor immunity using ...... NA vaccines in murine melanoma
@en
P2093
Alan N Houghton
Brian Chan
Gabrielle Rizzuto
Jedd D Wolchok
Karoline C Chiou
Stephanie L Terzulli
Taha Merghoub
Yvonne M Saenger
P2860
P304
P356
10.1158/0008-5472.CAN-08-2233
P407
P577
2008-12-01T00:00:00Z